Work

Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma

Year: 2022

Type: article

Study design: Clinical Trial

Source: British Journal of Haematology

DOI: 10.1111/bjh.18593

Authors: James R. Berenson, Daisy Martinez, Tahmineh Safaie, Ralph Boccia, Honghao Yang, Mehdi Moezi, Stephen Lim, Gary Schwartz, Shahrooz Eshaghian, Regina Swift, Benjamin M. Eades, Sean Bujarski, Bernard Regidor, Clara Kim, Susanna Kim, Robert Vescio

Institutions: Oncotherapeutics (United States), Institute for Myeloma & Bone Cancer Research, Center for Cancers and Blood Disorders, Cedars-Sinai Medical Center, Compassionate Cancer Care

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Incyte

OpenAlex ID: W4310950563

FWCI: 1.858

Cites: 27

Cited by: 11

Related to: 10